Ben Hickey
About Ben Hickey
Ben Hickey is the Vice President of Immuno-Oncology Marketing at Bristol-Myers Squibb and the Chief Commercial Officer at Halozyme Therapeutics.
Current Position at Halozyme Therapeutics
Ben Hickey is currently serving as the Chief Commercial Officer at Halozyme Therapeutics in San Diego, California, United States. He has been with Halozyme Therapeutics since September 2018, leveraging his extensive experience in oncology marketing to drive the company's commercial strategies in the biotechnology sector.
Vice President of Immuno-Oncology Marketing at Bristol-Myers Squibb
Ben Hickey holds the position of Vice President, Immuno-Oncology Marketing at Bristol-Myers Squibb in New York, New York, United States. In this role, he oversees marketing initiatives for the company's immuno-oncology portfolio, applying his expertise in this advanced field to enhance market presence and engagement strategies.
Career at Bristol-Myers Squibb
Ben Hickey has had a substantial and varied career at Bristol-Myers Squibb. From 2001 to 2014, he held multiple senior roles including Product Manager Finance, Product Manager Global Access and Reimbursement, Senior Product Manager for both Neuroscience Marketing and U.S. Access and Reimbursement, Director Strategy and Operations, Director Promotional Marketing for Dapagliflozin, Executive Director of Oncology Marketing, Vice President of Hematology and Erbitux, and currently Vice President of Immuno-Oncology Marketing. His tenure at Bristol-Myers Squibb has been marked by significant contributions to marketing, product management, and strategic operations.
Educational Background
Ben Hickey earned his Master of Business Administration (MBA) from St. John’s University, with his studies spanning from 1998 to 2000. This academic background has provided him a strong foundation in business principles, which he has successfully implemented throughout his career in the pharmaceutical and biotechnology industries.
Expertise in Oncology Marketing
Ben Hickey possesses extensive expertise in oncology marketing. His professional journey has seen him play pivotal roles in various marketing and commercial strategies, particularly in the fields of hematology and immuno-oncology. His strategic leadership and in-depth knowledge of the oncology market have been key assets in his roles at both Halozyme Therapeutics and Bristol-Myers Squibb.